First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b
Clinical trial NCT06050356 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06050356
- Sponsor
- Statens Serum Institut
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-14
- Primary completion
- 2026-12-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.